MHRA Flags Multiple Device Safety Notices Across Diagnostics, Imaging, and Hospital Equipment
The Medicines and Healthcare products Regulatory Agency has published a new batch of field safety notices covering medical devices used in emergency testing, anesthesia, interventional imaging, assistive care, and other clinical settings. The list spans products from Abbott, Beckman Coulter, Medtronic, Philips, Maquet Critical Care, Convatec, Liko, NOxBOX Ltd, Cambridge Brain Sciences, American Orthodontics, and others, all issued in early to mid-October 2026 and published by MHRA on 19 October 2026.
The regulatory message is blunt: if a manufacturer sends a field safety notice, healthcare organizations must act on it. MHRA is publishing the notices for information only and directs questions about any specific notice to the manufacturer. In practice, this means device users, biomedical engineering teams, procurement leads, and clinical governance staff need to review the relevant alert, identify whether the affected model is in service, and follow the manufacturer’s instructions without delay.
Device Alerts Span Bedside Testing, Ventilation, and Procedural Imaging
The notices in this release cover a broad swath of the clinical workflow. Abbott’s i-STAT hs-TnI cartridge appears on the list, a product tied to troponin testing and therefore to rapid triage of suspected myocardial injury. When a troponin assay is subject to a safety notice, the consequences can reach far beyond the laboratory bench, because turnaround time, assay reliability, and repeat testing shape decisions in chest pain pathways and acute coronary syndrome evaluation.
Other notices touch equipment that sits much closer to the airway, the procedure room, or the patient transfer environment. Maquet Critical Care AB lists the Flow-i C20, Flow-i C30, Flow-i C40, Flow-c, and Flow-e anesthesia systems. NOxBOX Ltd lists NOXBOXi. Philips Medical Systems Nederland BV lists Philips Azurion interventional fluoroscopic X-ray systems, with multiple model numbers attached. These are not peripheral devices. They sit inside high-acuity care where a malfunction, configuration problem, or labeling issue can interrupt anesthesia delivery, delay intervention, or force a temporary workaround in procedures that often tolerate very little disruption.
One-sentence reality: device vigilance is a patient-safety task, not an administrative one.
Why the MHRA List Matters in Day-to-Day Clinical Operations
Field safety notices occupy a very specific place in medical regulation. They are manufacturer-driven safety communications meant to correct or reduce risk when a device in the field no longer matches the expected performance, labeling, or safe-use assumptions established at release. In hospital practice, the response is rarely abstract. Devices may need to be checked against serial numbers, model ranges, or installation records; staff may need retraining; and clinical pathways may need temporary adjustment while the affected equipment remains under review.
The current list also shows how broad the risk surface can be. American Orthodontics Corp lists Orthodontic Metal Devices. Convatec Ltd lists ESENTA Stomahesive Paste, a peristomal and peri-wound dressing product used in stoma care and wound management. Cambridge Brain Sciences o/a Creyos appears in the list as well, extending the alert set beyond classic hardware into digital or cognitive-assessment-related products. Liko AB’s Likorall Overhead Lift is included too, reminding readers that assistive transfer systems can be just as safety-sensitive as monitors or imaging equipment when patients rely on them for mobility and staff rely on them to prevent falls or handling injuries.
A second one-sentence reality: when a notice involves a device used multiple times a day, even a narrow issue can become a systems problem.
What Clinical Teams Need to Do With This Type of Notice
The practical response starts with identification. Teams need to determine whether the named product is present in the institution, whether any listed model or version matches local inventory, and whether the device is still in clinical circulation. The MHRA page provides reference numbers and links for each notice, but the safety action itself belongs to the manufacturer and the local organization that manages the device. For devices embedded in laboratory, theater, radiology, and intensive care workflows, that process often requires coordination across several departments rather than a single service line.
Because the page is a registry rather than a detailed incident report, it does not describe the specific defect, harm signal, or mitigation step for each product. Even so, the publication itself signals a regulatory event with operational implications. A troponin cartridge, an anesthesia machine, an interventional X-ray system, and an overhead lift do not fail in the same way, but they share one common feature: if a safety notice reaches the field, clinicians cannot assume routine use remains unchanged.
That is especially true for systems with direct exposure to critically ill patients. Anesthesia devices support ventilation and gas delivery. Interventional fluoroscopic systems support diagnosis and treatment during complex procedures. Point-of-care biomarker cartridges guide rapid decisions in emergency medicine. Transfer lifts and stoma-care products affect safe handling and skin integrity. Each of these devices has a different failure mode, yet each can alter patient care immediately if a problem is left unresolved.
The MHRA’s publication also extends back to its archive of field safety notices since 2020 and, for older items, to National Archives records before November 2014. This indicates the agency’s ongoing surveillance role and the expectation that healthcare providers keep a durable system for tracking device alerts over time, not just reacting to the latest release. The operational burden is real: procurement records age, model numbers proliferate, and one institution may carry several generations of the same platform.
In that setting, the question is not whether a notice deserves attention. It does. The more difficult task is making sure the right teams see the right notice quickly enough to act before the device is used again.